Hemostasis and Thrombosis

Inhibitors.- Assays to Monitor Bivalirudin.- Monitoring of Anti-Platelet Therapy.- Heparin Induced Thrombotic Thrombocytopenia (HITT) and Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT): Similar by Different.- Functional Testing for Heparin Induced Thrombocytopenia using Whole Blood Multiplate Impedance Aggregometry.- Multiple Electrode Aggregometry (Multiplate): Functional Assay for Vaccine Induced (Immune) Thrombotic Thrombocytopenia (VITT).- Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.- Serotonin Release Assay: Functional Assay for Heparin and Vaccine Induced (Immune) Thrombotic Thrombocytopenia.- An Overview of Laboratory Testing for ADAMTS13.- Automated and Rapid ADAMTS13 Testing using Chemiluminescence: Utility for Identification or Exclusion of TTP and Beyond.- Identification of ADAMTS13Inhibitors in Acquired TTP.- ADAMTS13 Activity: Screening Test Protocol.- ADAMTS13 Activity Measurement by ELISA and Fluorescence Resonance Energy Transfer Assay.- ADAMTS13 Antibody and Inhibitor Assays.- A Review of Factor VIII and Factor IX Assay Methods for Monitoring Extended Half-Life Products in Haemophilia A and B.- Measuring Emicizumab Levels in the Hemostasis Laboratory.- Chromogenic Factor VIII Assay for Patients with Haemophilia A and On Emicizumab Therapy.- Assessment of Platelet Function by Automated Light Transmission Aggregometry.- Assessment of Platelet Function by High-Throughput Screening Light Transmittance Aggregometry: Optimul Assay.- Preparing Surrogate Abnormal Quality Samples for Platelet Function Studies and Viscoelastic Testing.- Laboratory Testing for von Willebrand Disease Using a Composite Rapid 3-Test Chemiluminescence-Based von Willebrand Factor Assay Panel.- Laboratory Testing for von Wilebrand Factor Activity by a Glycoproein Ib Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP®.- Laboratory Testing for von Willebrand Factor:Factor VIII Binding for Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.- Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement.- Measurement of Blood Viscoelasticity using Thromboelastography.- The TEG 5000© System: System Description and Protocol for Measurements.- The TEG 6s© System: System Description and Protocol for Measurements.- The Quantra® System: System Description and Protocols for Measurements.- Modified Rotational Thromboelastometry Protocol using Tissue Plasminogen Activator for Detection of Hypofibrinolysis and Hyperfibrinolysis.- Protocol for the Investigation of Plasma and Whole Blood Clot Property of Fibrin Fiber Thickness using Scanning Electron Microscopy.- Post-Analytical Issues in Hemostasis and ThrombosisTesting: An Update.